β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE

We are β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE CAS:182955-12-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE
CAS.NO:182955-12-0
Synonyms:β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE
3-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE
4-(4-CHLORO-PHENYL)-DIHYDRO-PYRAN-2,6-DIONE
SS-(4-CHLOROPHENYL) GLUTARIC ANHYDRIDE
B-(4-CHLOROPHENYL) GLUTARIC ANHYDRIDE
 
Physical and Chemical Properties:
Density 1.348g/cm3
Boiling Point 393.2ºC at 760 mmHg
Molecular Formula C11H9ClO3
Molecular Weight 224.64000
Flash Point 176ºC
Vapour Pressure 2.17E-06mmHg at 25°C
Index of Refraction 1.564
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Baclofen(CAS:1134-47-0).

β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.3- (dietilamino) fenol, ácido sulfúrico CAS:68239-84-9 Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.N-Sulphamyl-3-chloropropionamidine hydrochloride CAS:106649-95-0 This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.137234-74-3 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.

Related Products
Product Name
2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid View Details
5-CHLOROPENTYL ACETATE View Details
((2R,3R,5S)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate View Details
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate manufacturer 2,6-Difluorobenzyl bromide manufacturer 6,7-bis(2-methoxyethoxy)-1H-quinazolin-4-one manufacturer 4-Chloro-3-methylisoxazol-5-amine manufacturer 3-Fluorotoluene manufacturer